Skip to main content
Erschienen in: Herz 3/2015

01.05.2015 | Original article

Diastolic dysfunction and contrast-induced nephropathy in patients undergoing coronary angiography

verfasst von: Dr. S. Acikel, R. Akdemir, H. Kilic, G. Cagirci, M. Dogan, A.B. Yesilay, E. Yeter

Erschienen in: Herz | Sonderheft 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

It has been demonstrated that decreased left ventricular ejection fraction (LVEF) is associated with an increased risk of contrast-induced nephropathy (CIN). In this study, we aimed to assess whether there is a relationship between left ventricular (LV) diastolic dysfunction and renal function decline after coronary angiography (CAG).

Patients and methods

The study consisted of two groups: group I, patients with normal diastolic function; group II, patients with cardiac symptoms and abnormal diastolic function. Serum creatinine (Crea) and glomerular filtration rates (GFR) were measured before and after 48 h of CAG.

Results

After the procedure, serum Crea values were higher in group II compared with group I (p = 0.051). Postprocedural 48-h GFR values determined by Cockcroft–Gault and Modification of Diet in Renal Disease (MDRD) equations were lower in group II compared with group I (p = 0.016 and p = 0.003, respectively). Delta (Δ) ΔCrea and ΔGFR determined by the Cockcroft–Gault and MDRD equations were statistically higher in group II than in group I (p = 0.005, p = 0.052, p = 0.030). The presence of higher age (p = 0.025), E/E’ lateral ratio (p = 0.030), and left atrial volume index (p = 0.05) were independent predictors of worsening renal function.

Conclusion

The presence of diastolic dysfunction may play a role in determining the risk of CIN in patients with normal LVEF.
Literatur
1.
Zurück zum Zitat McCullough PA, Adam A, Becker CR et al (2006) Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98:5–13CrossRef McCullough PA, Adam A, Becker CR et al (2006) Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98:5–13CrossRef
2.
3.
Zurück zum Zitat Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548CrossRefPubMed Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548CrossRefPubMed
4.
Zurück zum Zitat McCullough PA, Adam A, Becker CR et al (2006) Risk prediction of contrast-induced nephropathy. Am J Cardiol 98:27–36CrossRef McCullough PA, Adam A, Becker CR et al (2006) Risk prediction of contrast-induced nephropathy. Am J Cardiol 98:27–36CrossRef
5.
Zurück zum Zitat Rosenstock JL, Gilles E, Geller AB et al (2010) Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 42:1049–1054CrossRefPubMed Rosenstock JL, Gilles E, Geller AB et al (2010) Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 42:1049–1054CrossRefPubMed
6.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed
7.
Zurück zum Zitat Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133CrossRefPubMed Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133CrossRefPubMed
8.
Zurück zum Zitat Devereux RB, Alonso DR, Lutas EM et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed Devereux RB, Alonso DR, Lutas EM et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed
9.
Zurück zum Zitat Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41CrossRefPubMed Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41CrossRefPubMed
10.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med130:461–470CrossRef Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med130:461–470CrossRef
11.
Zurück zum Zitat Maioli M, Toso A, Gallopin M et al (2010) Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention. J Cardiovasc Med 11:444–449CrossRef Maioli M, Toso A, Gallopin M et al (2010) Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention. J Cardiovasc Med 11:444–449CrossRef
12.
Zurück zum Zitat Kagan A, Sheikh-Hamad D (2010) Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies. Clin Cardiol 33:62–66CrossRefPubMed Kagan A, Sheikh-Hamad D (2010) Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies. Clin Cardiol 33:62–66CrossRefPubMed
13.
14.
Zurück zum Zitat Yamamoto K, Sakata Y, Ohtani T et al (2009) Heart failure with preserved ejection fraction. Circ J 73:404–410CrossRefPubMed Yamamoto K, Sakata Y, Ohtani T et al (2009) Heart failure with preserved ejection fraction. Circ J 73:404–410CrossRefPubMed
15.
Zurück zum Zitat Niethammer M, Sieber M, Haehling S von et al (2008) Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol 129:111–117CrossRefPubMed Niethammer M, Sieber M, Haehling S von et al (2008) Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol 129:111–117CrossRefPubMed
16.
Zurück zum Zitat Kosmala W, Derzhko R, Przewlocka-Kosmala M et al (2008) Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coron Artery Dis 19:375–382CrossRefPubMed Kosmala W, Derzhko R, Przewlocka-Kosmala M et al (2008) Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coron Artery Dis 19:375–382CrossRefPubMed
17.
Zurück zum Zitat Kalogeropoulos A, Georgiopoulou V, Psaty BM et al (2010) Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol 55:2129–2137CrossRefPubMedCentralPubMed Kalogeropoulos A, Georgiopoulou V, Psaty BM et al (2010) Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol 55:2129–2137CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Mohammed SF, Ohtani T, Korinek J et al (2010) Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via “nongenomic effects”. Circulation 122:370–378CrossRefPubMedCentralPubMed Mohammed SF, Ohtani T, Korinek J et al (2010) Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via “nongenomic effects”. Circulation 122:370–378CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Sciarretta S, Paneni F, Palano F et al (2009) Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci 116:467–477CrossRefPubMed Sciarretta S, Paneni F, Palano F et al (2009) Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci 116:467–477CrossRefPubMed
20.
Zurück zum Zitat Rusinaru D, Buiciuc O, Houpe D, Tribouilloy C (2011) Renal function and long-term survival after hospital discharge in heart failure with preserved ejection fraction. Int J Cardiol 147:278–282CrossRefPubMed Rusinaru D, Buiciuc O, Houpe D, Tribouilloy C (2011) Renal function and long-term survival after hospital discharge in heart failure with preserved ejection fraction. Int J Cardiol 147:278–282CrossRefPubMed
21.
Zurück zum Zitat Ronco C, Haapio M, House AA et al (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539CrossRefPubMed Ronco C, Haapio M, House AA et al (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539CrossRefPubMed
22.
Zurück zum Zitat Ronco C, Maisel A (2010) Volume overload and cardiorenal syndromes. Congest Heart Fail 16:S1–S4CrossRef Ronco C, Maisel A (2010) Volume overload and cardiorenal syndromes. Congest Heart Fail 16:S1–S4CrossRef
23.
Zurück zum Zitat Shamseddin MK, Parfrey PS (2009) Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol 5:641–649CrossRefPubMed Shamseddin MK, Parfrey PS (2009) Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol 5:641–649CrossRefPubMed
Metadaten
Titel
Diastolic dysfunction and contrast-induced nephropathy in patients undergoing coronary angiography
verfasst von
Dr. S. Acikel
R. Akdemir
H. Kilic
G. Cagirci
M. Dogan
A.B. Yesilay
E. Yeter
Publikationsdatum
01.05.2015
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe Sonderheft 3/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-014-4173-3

Weitere Artikel der Sonderheft 3/2015

Herz 3/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.